If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
346.60    -4.00 (-1.14%)
Bid:
346.60
Ask:
346.80
Spread: 0.20 (0.058%)
Market Cap: £2.52b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Directorate Change

21 Jun 2018 13:00

RNS Number : 1687S
TP ICAP PLC
21 June 2018
 

TP ICAP appoints Lorraine Trainer as Non-Executive Director

 

[London, 21 June 2018] - TP ICAP plc, the world's largest interdealer broker, is pleased to announce the appointment of Lorraine Trainer to the role of Non-Executive Director and as a member of the company's Remuneration, Audit and Nominations and Governance Committees. She will assume the positions with effect from 1 July 2018. As indicated in the 2017 Annual Report, Stephen Pull, Chairman of the Remuneration Committee, will be retiring from the Board in the first few months of 2019. Lorraine will take over as Chairman of the Remuneration Committee at that time.

 

Ms. Trainer has had an established career in HR leadership across financial institutions including Citibank NA, London Stock Exchange and Coutts NatWest Group, before setting up the mentoring business at Manchester Square Partners. She also spent time at De Beers LV Ltd focusing on human resources and customer experience. Ms. Trainer is currently a Non-Executive Director and member of the Board Nominations and Remuneration Committee of Sonae, one of the largest family-owned listed companies in Portugal, with interests in shopping centres, food, sport and fashion retail and media and telecommunications; and a Non-Executive Director and Chair of the Remuneration Committee at Essentra, a leading global provider of essential components and packaging. Ms. Trainer has previously served as the Senior Independent Director and Chair of the Remuneration Committee at Jupiter Fund Management, and as a Non-Executive Director and Chair of the Remuneration Committee at Colt Group and Aegis Group.

 

Commenting on Ms. Trainer's appointment, Rupert Robson, Chairman of TP ICAP, said: "We are very pleased to welcome Lorraine to the Board of TP ICAP. She brings substantial experience, both from her executive career, as well as from her directorship roles, and will be a great addition to our Board."

 

TP ICAP plc confirms that there are no other details that are required to be disclosed under 9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

- Ends -

 

Enquiries:

 

Jamie Dunkley, Group Media Relations Director

+44 (0) 20 7200 7524

 

Brian Buckley / Eilis Murphy, Brunswick

+44 (0) 20 7404 5959

 

About TP ICAP

 

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data &; analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

 

www.tpicap.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAFKFALAPEFF
Date   Source Headline
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20254:45 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20254:30 pmRNSHolding(s) in Company
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:05 amRNSLaunch of fourth share buyback programme of £30m
11th Mar 20257:00 amRNSFinal Results
6th Mar 20254:35 pmRNSHolding(s) in Company
13th Feb 20258:00 amRNSHolding(s) in Company
10th Feb 20254:30 pmRNSHolding(s) in Company
23rd Jan 20255:30 pmRNSDirectorate Change
17th Jan 20252:45 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 202410:21 amRNSHolding(s) in Company
20th Dec 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20244:15 pmRNSHolding(s) in Company
13th Nov 20243:00 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:05 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.